These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17045067)

  • 1. Unanswered questions arising from the continuous relationship between glucometabolic state and cardiovascular risk.
    Tonkin AM; Chen L
    Curr Atheroscler Rep; 2006 Nov; 8(6):439-40. PubMed ID: 17045067
    [No Abstract]   [Full Text] [Related]  

  • 2. Modifiable risk factors in midlife and the age of onset of diabetes mellitus: a 34-year follow-up study.
    Pienimäki T; Strandberg AY; Pitkälä KH; Tilvis RS; Miettinen TA; Salomaa V; Strandberg TE
    J Am Geriatr Soc; 2012 Jan; 60(1):174-6. PubMed ID: 22239309
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetes: Lower risk of cardiovascular death with canagliflozin.
    Huynh K
    Nat Rev Cardiol; 2017 Aug; 14(8):442. PubMed ID: 28660893
    [No Abstract]   [Full Text] [Related]  

  • 4. [Basal insulin has a "neutral effect" on cardiovascular events].
    Overbeck P
    MMW Fortschr Med; 2012 Jun; 154(12):24. PubMed ID: 22880290
    [No Abstract]   [Full Text] [Related]  

  • 5. [Impact of antidiabetic therapy on the risk of cardiovascular diseases and their complications in patients with type 2 diabetes mellitus].
    Ametov AS; P'ianykh OP; Chernikova NA
    Ter Arkh; 2010; 82(8):71-5. PubMed ID: 20873250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 2 diabetes and macrovascular disease: epidemiology and etiology.
    Clark CM; Perry RC
    Am Heart J; 1999 Nov; 138(5 Pt 1):S330-3. PubMed ID: 10539793
    [No Abstract]   [Full Text] [Related]  

  • 7. Diabetes and cardiovascular disease. Introduction.
    Chait A
    Atheroscler Suppl; 2006 Aug; 7(4):1-4. PubMed ID: 16822721
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intensive blood glucose lowering to reduce cardiovascular risk: pro].
    Martin S
    Dtsch Med Wochenschr; 2009 May; 134(20):1060. PubMed ID: 19421929
    [No Abstract]   [Full Text] [Related]  

  • 9. Visit-to-Visit Variability of Fasting Plasma Glucose and the Risk of Cardiovascular Disease and All-Cause Mortality in the General Population.
    Wang A; Liu X; Xu J; Han X; Su Z; Chen S; Zhang N; Wu S; Wang Y; Wang Y
    J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29187392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of glucose control in type 2 diabetes: session summary.
    Stern MP
    Diabetes Care; 1999 Apr; 22 Suppl 3():C57-60. PubMed ID: 10375291
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes.
    Colette C; Monnier L
    Horm Metab Res; 2007 Sep; 39(9):683-6. PubMed ID: 17846977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intensive blood glucose lowering to reduce cardiovascular risk: contra].
    Marx N
    Dtsch Med Wochenschr; 2009 May; 134(20):1061. PubMed ID: 19421930
    [No Abstract]   [Full Text] [Related]  

  • 13. Obesity, Diabetes, and Cardiovascular Diseases: A Compendium.
    Scherer PE; Hill JA
    Circ Res; 2016 May; 118(11):1703-5. PubMed ID: 27230636
    [No Abstract]   [Full Text] [Related]  

  • 14. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes.
    Kengne AP; Patel A; Marre M; Travert F; Lievre M; Zoungas S; Chalmers J; Colagiuri S; Grobbee DE; Hamet P; Heller S; Neal B; Woodward M;
    Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):393-8. PubMed ID: 21450612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Levels of Apolipoproteins and Incident Type 2 Diabetes: A Prospective Cohort Study.
    Brahimaj A; Ligthart S; Ikram MA; Hofman A; Franco OH; Sijbrands EJ; Kavousi M; Dehghan A
    Diabetes Care; 2017 Mar; 40(3):346-351. PubMed ID: 28031419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysglycaemia and risk of cardiovascular disease.
    Gerstein HC; Yusuf S
    Lancet; 1996 Apr; 347(9006):949-50. PubMed ID: 8598762
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperglycemia as a risk factor for cardiovascular disease in type 2 diabetes.
    Laakso M
    Prim Care; 1999 Dec; 26(4):829-39. PubMed ID: 10523462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular importance of hyperglycemia and hypoglycemia.
    Tkác I
    Diabetes Care; 2013 Aug; 36 Suppl 2(Suppl 2):S267-71. PubMed ID: 23882057
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuum.
    Karasik A
    Ann Med; 2005; 37(4):250-8. PubMed ID: 16019723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk in type 2 diabetes.
    Standl E
    Diabetes Obes Metab; 1999 Sep; 1 Suppl 2():S24-36. PubMed ID: 11221799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.